Scientists at the Genome Institute of Singapore (GIS) have
unraveled the mechanism that causes liver cancer (hepatocellular
carcinoma, HCC), one of the most common solid tumors worldwide. This
genome-wide research was done in collaboration with colleagues from the
National University of Singapore (NUS), University of Hong Kong, Eli
Lilly & Co. USA, Merck Research Laboratories USA, Pfizer Oncology
USA and Beijing Genomics Institute China.
The discovery was published in the prestigious scientific journal, Nature Genetics,
on 27 May 2012. The GIS is a research institute under the umbrella of
the Agency for Science, Technology and Research (A*STAR).
One major cause of liver cancer,
or HCC, is high exposure to the hepatitis B virus (HBV), resulting in
the integration of HBV into the victim’s genes. Individuals who carry
the HBV have a greater than 100-fold increased relative risk of
developing HCC, considered to be a serious global health problem by the
World Health Organization (WHO).
Read more....
Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.
Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate
Subscribe to:
Post Comments (Atom)
thanks for sharing.
ReplyDelete